首页> 外文期刊>Regulatory peptides. >Participation of the inducible nitric oxide synthase on atrial natriuretic peptide plasma concentration during endotoxemic shock.
【24h】

Participation of the inducible nitric oxide synthase on atrial natriuretic peptide plasma concentration during endotoxemic shock.

机译:内毒素休克期间诱导型一氧化氮合酶对心钠素血浆浓度的参与

获取原文
获取原文并翻译 | 示例
           

摘要

Atrial natriuretic peptide (ANP) is a hormone secreted in response to atrial or ventricular volume expansion and pressure overload, respectively. However, it has been found in studies with animals and patients an increase in ANP plasma concentration, during advanced septic shock, despite the fall in mean arterial pressure (MAP). Several studies support the hypothesis that NO may be involved in the regulation of ANP release. Since NO may have an effect on ANP release, we hypothesized that NO pathway may participate in the control of the ANP release induced by the endotoxemic shock. Thus, the purpose of the present study was to assess the effect of the intravenous (i.v.) and intracereboventricular (i.c.v.) administration of aminoguanidine, an iNOS blocker, on plasma ANP levels and MAP during experimental endotoxemic shock. Experiments were performed on adult male Wistar rats weighing 180-240 g. Rats were injected i.v. by bolus injection with 1.5 mg/kg of Lipopolysaccharide (LPS) or saline (0.5 mL) and were decapitated 2, 4 and 6 h after LPS injection for ANP determination by radioimmunoassay. In a separate set of experiments, rats received intravenous (i.v.) (100 mg/kg) or intracerebroventricular (i.c.v.) (250 mug in a final volume of 2 muL) injection of aminoguanidine (AG). Thirty minutes after the i.c.v. or i.v. injections, animals received LPS and were decapitated 2, 4 and 6 h later to determine plasma ANP concentration. In the two set of experiments MAP and heart rate (HR) were measured each 15 min for a period of 6 h using a polygraph. When animals were injected with LPS, a reduction (p<0.01) in MPA and an increase in HR occurred. A significant increase in plasma ANP concentration occurred, coinciding with the period of drop in blood pressure. We found a significant increase in plasma ANP concentration after AG plus LPS injection, when compared to the rats treated with LPS plus saline. Further, the administration of AG plus LPS attenuated the decrease in the MAP after LPS and attenuated the increase in the HR when compared to the rats treated with LPS plus saline. Our study suggests that inducible NOS pathway may activate an inhibitory control mechanism that attenuates ANP secretion, which is not regulated by the changes in blood pressure.
机译:心钠素(ANP)是一种分泌的激素,分别响应于心房或心室的体积膨胀和压力超负荷。然而,在对动物和患者的研究中发现,尽管平均动脉压(MAP)下降,但在晚期脓毒性休克期间ANP血浆浓度会增加。几项研究支持NO可能参与ANP释放调节的假设。由于NO可能会影响ANP的释放,我们假设NO途径可能参与了内毒素休克诱导的ANP释放的控制。因此,本研究的目的是评估内毒素血症性休克期间静脉内(i.v.)和脑室内(i.c.v.)施用氨基胍(iNOS阻滞剂)对血浆ANP水平和MAP的影响。实验是在体重180-240克的成年雄性Wistar大鼠上进行的。大鼠静脉内注射。通过推注1.5 mg / kg的脂多糖(LPS)或盐水(0.5 mL)进行注射,并在LPS注射后2、4和6 h断头以进行放射免疫测定的ANP。在另一组实验中,大鼠接受了氨基胍(AG)的静脉内(i.v.)(100 mg / kg)或脑室内(i.c.v.)(250杯,最终体积为2μL)注射。静脉注射后30分钟或i.v.注射后,动物接受LPS并在2、4和6小时后断头以确定血浆ANP浓度。在两组实验中,使用测谎仪每15分钟测量MAP和心率(HR),持续6小时。当给动物注射LPS时,MPA降低(p <0.01),HR升高。血浆ANP浓度显着增加,与血压下降时间一致。与用LPS加盐水治疗的大鼠相比,我们发现AG加LPS注射后血浆ANP浓度显着增加。此外,与用LPS加生理盐水治疗的大鼠相比,AG加LPS的给药减弱了LPS后MAP的降低,并减弱了HR的升高。我们的研究表明,诱导型NOS途径可能激活抑制ANP分泌的抑制性控制机制,而后者不受血压变化的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号